Development of an innovative tool for automatic assessment of heart rhythm and conduction disorders in pediatric patients
Project title
Development of an innovative tool for automatic assessment of heart rhythm and conduction disorders in pediatric patients
Name of Beneficiary/Beneficiaries
Cardiomatics Sp. z o.o.
Name of programme
Operational Program “Smart Growth”
Competition
Fast Track
Project value
PLN 5,592,260.70
Funding value
PLN 4,166,783.56
Project delivery period
01.10.2020 – 30.06.2023
Results of our work
Video
Issues addressed
The Cardiomatics Junior project focuses on solving a key problem in pediatric healthcare: lack of specialized tools for precise analysis of electrocardiograms (ECG) in children. Conventional ECG systems, designed mainly for adults, are often not adapted to the specific diagnostic needs of children who differ from adults in terms of physiology and morphology. This state of affairs may lead to errors in diagnosis and delays in starting treatment and increases the risk of missing serious cardiac diseases in the youngest patients.
Cardiomatics Junior, using advanced artificial intelligence (AI) technologies, provides a solution that specializes in the interpretation of pediatric ECG records. The AI system is trained on huge datasets, which allows it to scientifically recognize and analyze subtle heart rhythm anomalies that may escape conventional diagnostic methods. With this tool, doctors can quickly and precisely identify potential risks to heart health in children, which is crucial for early intervention and effective treatment.
Moreover, the project fits into the increasingly popular trend of telemedicine. Cardiomatics Junior enables remote monitoring and analysis of ECG data, which is extremely valuable, especially in less accessible regions where access to specialized cardiac care is limited. Remote diagnostic capabilities enable continuous care and monitoring of heart health without the need for frequent visits to medical facilities, which is both convenient for patients’ families and cost-effective for health care systems.
Project beneficiaries
The results of the Cardiomatics Junior project will benefit a wide range of clients, including both direct users of the system and wider communities:
Pediatric cardiac patients and their families: As the main beneficiaries, children requiring cardiac diagnosis and monitoring will have access to faster and more accurate health assessments. Parents of these patients will benefit from greater peace of mind knowing that their children’s health is being monitored by a state-of-the-art tool.
Doctors and specialists in pediatric cardiology: Cardiomatics Junior provides specialists with a tool that increases the efficiency of diagnosis, enabling better management of treatment plans and faster response to potential health threats. Doctors can also use precise data to conduct research on heart disease in children.
Medical facilities and hospitals: Hospitals and clinics gain a tool that can help optimize diagnostic processes, saving time and costs associated with conventional diagnostic methods. More effective pediatric case management may also contribute to better use of medical resources.
As a result, Cardiomatics Junior is a valuable contribution to the field of pediatric cardiac care, with benefits ranging from direct diagnosis to impact on health policies and research.